Insider Trading & Ownership - LaBrosse Nicole

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for LaBrosse Nicole
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-07-22
Sale
2024-07-23
4:37 pm
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
5,000$53.93$269,66215,480
(Direct)
View
2024-06-26
Sale
2024-06-28
4:06 pm
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
30,000$51.93$1,557,94060,480
(Direct)
View
2023-02-16
Sale
2023-02-21
7:00 pm
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
2,525$49.26$124,382106,722
(Direct)
View
2022-11-15
Sale
2022-11-16
7:51 pm
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
5,000$53.81$269,0534,045
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-07-22
Exercise
2024-07-23
4:37 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
5,000$22.515,480
(Direct)
View
2024-07-22
Exercise
2024-07-23
4:37 pm
N/A
2025-07-01
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
5,000$015,480
(Direct)
View
2024-06-26
Exercise
2024-06-28
4:06 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
30,000$22.560,480
(Direct)
View
2024-06-26
Exercise
2024-06-28
4:06 pm
N/A
2025-07-01
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
30,000$060,480
(Direct)
View
2024-02-23
Option Award
2024-02-27
5:05 pm
2025-02-23
2034-02-23
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
54,473$054,473
(Direct)
View
2024-02-16
Exercise
2024-02-20
6:53 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
10,422$041,653
(Direct)
View
2024-02-16
Tax Withholding
2024-02-20
6:53 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
5,601$36.141,653
(Direct)
View
2024-02-15
Tax Withholding
2024-02-16
5:41 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
686$35.9111,913
(Direct)
View
2024-02-15
Exercise
2024-02-16
5:41 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
1,254$011,913
(Direct)
View
2024-02-10
Tax Withholding
2024-02-13
4:15 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
1,477$35.4910,091
(Direct)
View
2024-02-10
Exercise
2024-02-13
4:15 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
2,502$010,091
(Direct)
View
2023-02-16
Option Award
2023-02-21
7:00 pm
2024-02-16
2033-02-16
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
82,377$0106,722
(Direct)
View
2023-02-16
Exercise
2023-02-21
7:00 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
5,094$0106,722
(Direct)
View
2023-02-15
Tax Withholding
2023-02-17
06:25 am
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
621$49.29,005
(Direct)
View
2023-02-15
Exercise
2023-02-17
06:25 am
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
1,254$09,005
(Direct)
View
2023-02-10
Tax Withholding
2023-02-14
5:21 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
2,073$48.928,366
(Direct)
View
2023-02-10
Exercise
2023-02-14
5:21 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
3,892$08,366
(Direct)
View
2022-02-16
Option Award
2022-02-17
6:03 pm
2023-02-16
2032-02-16
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, Chief Financial Officer
82,688$095,495
(Direct)
View
2022-02-15
Tax Withholding
2022-02-17
6:03 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, Chief Financial Officer
433$34.4395,495
(Direct)
View
2022-02-15
Exercise
2022-02-17
6:03 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, Chief Financial Officer
1,255$095,495
(Direct)
View
2022-02-14
Tax Withholding
2022-02-14
7:28 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, Chief Financial Officer
427$33.6414,617
(Direct)
View
2022-02-10
Exercise
2022-02-14
7:28 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, Chief Financial Officer
5,148$014,617
(Direct)
View
2022-02-12
Tax Withholding
2022-02-14
7:28 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, Chief Financial Officer
506$34.214,617
(Direct)
View
2022-02-10
Tax Withholding
2022-02-14
7:28 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, Chief Financial Officer
1,025$34.9414,617
(Direct)
View

Ownership
2022-02-11
4:21 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOLaBrosse Nicole
SVP, Chief Financial Officer
0$0123,456
(Direct)
View